Cargando…
In vitro and in vivo effect of hyaluronic acid modified, doxorubicin and gallic acid co-delivered lipid-polymeric hybrid nano-system for leukemia therapy
Objective: To investigate the hyaluronic acid (HA) modified, doxorubicin (DOX) and gallic acid (GA) co-delivered lipid-polymeric hybrid nano-system for leukemia therapy. Methods: We produced a kind of lipid-polymer hybrid nanoparticle (LPHN) with a core-shell structure in which DOX and GA were co-lo...
Autores principales: | Shao, Yanping, Luo, Wenda, Guo, Qunyi, Li, Xiaohong, Zhang, Qianqian, Li, Jing |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6607984/ https://www.ncbi.nlm.nih.gov/pubmed/31388296 http://dx.doi.org/10.2147/DDDT.S202818 |
Ejemplares similares
-
Efficient Diethylzinc/Gallic Acid and Diethylzinc/Gallic Acid Ester Catalytic Systems for the Ring-Opening Polymerization of rac-Lactide
por: Żółtowska, Karolina, et al.
Publicado: (2015) -
Gallic acid
por: Zhao, Jianping, et al.
Publicado: (2011) -
Improving Anti-Cancer Potentiality and Bioavailability of Gallic Acid by Designing Polymeric Nanocomposite Formulation
por: Ahmed, Hanaa H, et al.
Publicado: (2018) -
Hyaluronic Acid-Modified and Doxorubicin-Loaded Gold Nanoparticles and Evaluation of Their Bioactivity
por: Li, Lin-Song, et al.
Publicado: (2021) -
Hyaluronic acid–doxorubicin nanoparticles for targeted treatment of colorectal cancer
por: Pan, Daniel C., et al.
Publicado: (2020)